PMOS Research Observatory

Explore PMOS Research

Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.

20,710 articles match

Total citations

289,983

Peak year

2025(3,021 articles)

Avg citations / article

14

Publications per year

All countries

Topics

All research areas

Endocrinology & Hormones12,696
Metabolic Health9,856
Fertility & Reproduction6,240
Epidemiology & Public Health3,114
Pharmacology & Treatment3,006
Diagnostics & Phenotyping2,317
Genetics & Genomics2,291
Mental Health & Psychology1,929

Countries

All countries

China3,806
United States2,435
India1,743
Iran1,194
Turkey922
United Kingdom754
Australia615
Italy475

Top journals

All filters

Fertility and Sterility584
Endocrine Abstracts510
Gynecological Endocrinology400
Frontiers in Endocrinology369
Figshare340
Journal of the Endocrine Society328
Human Reproduction275
Research Square (Research Square)270
PubMed258
The Journal of Clinical Endocrinology & Metabolism223

Top institutions

All filters

Monash University323
Tehran University of Medical Sciences234
Shanghai Jiao Tong University228
Shahid Beheshti University of Medical Sciences221
Peking University212
Shandong University177
Karolinska Institutet167
Peking University Third Hospital166
Monash Health165
University of Adelaide156

Where in the world is each topic being researched?

Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.

HormonesMetabolicFertilityEpidemiol.PharmaDiagnos.GeneticsMentalNutritionMolecularInflamm.Cell BioLifestyleMicrobiomeDermatol.
China1.00.91.10.91.10.71.50.40.71.91.12.10.51.40.2
United States1.01.11.01.30.81.10.91.40.60.60.70.61.00.61.3
India0.90.90.90.90.91.91.11.11.70.80.70.61.21.21.9
Iran1.00.90.90.91.60.50.71.21.80.92.00.71.10.90.8
Turkey1.21.20.80.40.41.40.51.01.00.61.70.50.41.31.4
United Kingdom0.91.00.91.31.00.90.82.00.90.50.70.31.80.51.3
Australia0.81.10.91.91.10.80.62.10.70.20.10.54.00.40.5
Italy1.11.21.00.80.91.20.50.81.50.60.70.30.51.01.0
Egypt1.00.81.90.41.70.80.40.61.10.61.00.50.30.32.2
Poland1.31.40.50.60.40.80.61.20.80.61.20.41.11.71.6
Under-specialised
Specialised|RCA > 1 = country focuses on this topic more than average

Studies3,3413,360 of 20,710

All studies

Resveratrol improves follicular development in PCOS rats by inhibiting the inflammatory response and pyroptosis of granulosa cells

2024Biology of Reproduction9 citationsDOI ↗
Endocrinology & HormonesFertility & ReproductionInflammation & Oxidative Stress

The effects of acupuncture on patients with premature ovarian insufficiency and polycystic ovary syndrome: an umbrella review of systematic reviews and meta-analyses

2024Frontiers in Medicine9 citationsDOI ↗
Epidemiology & Public HealthPharmacology & TreatmentPremature Ovarian Insufficiency

Osthole exhibits the remedial potential for polycystic ovary syndrome mice through Nrf2‐Foxo1‐GSH‐NF‐κB pathway

2024Cell Biology International9 citationsDOI ↗
Endocrinology & HormonesInflammation & Oxidative StressPharmacology & Treatment

Cut‐off value for anti‐Müllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population

2024Journal of obstetrics and gynaecology research9 citationsDOI ↗
Diagnostics & PhenotypingEndocrinology & HormonesFertility & Reproduction

A review of metabolic and microbial influences on women with polycystic ovarian syndrome.

2024Steroids9 citationsDOI ↗
Epidemiology & Public HealthGut MicrobiomeMetabolic Health

Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome?

2024Seminars in Reproductive Medicine9 citationsDOI ↗
Diagnostics & PhenotypingEndocrinology & Hormones

Pharmacological management of polycystic ovary syndrome

2024Australian Prescriber9 citationsDOI ↗
Endocrinology & HormonesMetabolic HealthPharmacology & TreatmentCardiovascular DiseaseType 2 Diabetes

Polycystic ovarian syndrome (PCOS) and recurrent spontaneous abortion (RSA) are associated with the PI3K-AKT pathway activation

2024PeerJ9 citationsDOI ↗
Cell Biology & Animal ModelsFertility & ReproductionGenetics & Genomics

Fertility and age at childbirth in polycystic ovary syndrome: results from a longitudinal population-based cohort study

2024American Journal of Obstetrics and Gynecology9 citationsDOI ↗
Epidemiology & Public HealthFertility & Reproduction

Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome

2024Food Science & Nutrition9 citationsDOI ↗
Endocrinology & HormonesGut MicrobiomeMetabolic Health

METTL3-mediated m6A modification of CD36: Implications for glucose metabolism and inflammatory dysregulation in follicles of polycystic ovary syndrome

2024International Immunopharmacology9 citationsDOI ↗
Endocrinology & HormonesInflammation & Oxidative StressMetabolic Health

Detection and Classification of Polycystic Ovary Syndrome using Machine Learning-Based Approaches

20249 citationsDOI ↗
Diagnostics & PhenotypingMetabolic HealthType 2 Diabetes

Comorbidities in women with polycystic ovary syndrome: a sibling study

2024BMC Women s Health9 citationsDOI ↗
Epidemiology & Public HealthMental Health & PsychologyMetabolic Health